Replimune (REPL) Net Equity Issued and Repurchased (2019 - 2026)

Replimune has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at -$10.4 million in Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$10.4 million in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $10.4 million (changed N/A YoY) and the FY2023 annual result came in at $149.9 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased fell to -$10.4 million in Q1 2026 per REPL's latest filing, from $10.4 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $242.6 million in Q4 2022 and troughed at -$48.2 million in Q4 2024.
• A 5-year average of $35.0 million and a median of $8.5 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 121.5% in 2025, down 121.5% in 2025.
• Over 5 years, Net Equity Issued and Repurchased stood at $242.6 million in 2022, then tumbled by 100.1% to -$248000.0 in 2023, then sank by 19337.1% to -$48.2 million in 2024, then jumped by 121.5% to $10.4 million in 2025, then slumped by 200.0% to -$10.4 million in 2026.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$10.4 million, $10.4 million, and -$48.2 million for Q1 2026, Q4 2025, and Q4 2024 respectively.